top of page

Help us Approve DCA for kids with PDCD

1000

Pyruvate Dehydrogenase Complex Deficieny (PDCD) is a rare and life-limiting neurodegenerative disease. There are approximately 1,000 children suffering from PDCD in the U.S.

0

There are currently 0 approved treatments for PDCD. If it had been approved, Sodium Dichloroacetate (DCA) would have provided significant quality of life improvements to children that desperately need it. 

12

The initial meeting with the FDA regarding DCA for the treatment of PDCD was over 12 years ago. Our kids can't wait any longer for access to this life changing medication.

Our families and kids are suffering.
PDCD does not wait.

Many children with PDCD die in infancy. Those that survive often face severe neurological, developmental, and physical challenges, including:

Severe Energy Depletion

Inability to Communicate

Intellectual

Disability

Developmental

Delay

Muscle Weakness / Limited Mobility

Irreversible Brain Damage

For more information on PDCD, check out the Hope for PDCD website

DCA is filling a critical unmet need

In September, the PDCD community was devastated by the news that Sodium Dichloroacetate (DCA) was not approved by the Food and Drug Administration (FDA). There were no safety concerns, the FDA essentially did not see the benefit. 

PDCD is a rare disease, making it exceedingly difficult to produce any statistically significant information during a clinical trial. 

For those that know these kids best, the moms, dads, caregivers, grandparents, and teachers; the quality of life benefits from DCA have been huge.  We've seen increases in energy and alertness, less pain, and milestones reached that we never dreamed possible. 

We are asking the FDA to please sit down with us and hear our lived experiences, to hear first hand what an approval of DCA would mean to our community. Our children's lives are at stake and they don't have time to wait.​​

DCA in the News

news_012.png
news_02.png
news_03.png
Webnews_pinksheet2.png
news_07.png
news_09.png
news_11.png
news_05.png
news_01.png
Website news_LawEnforcementToday.png
news_06.png
news_08.png
news_10.png
news_12.png

DCA Updates

PDCD Butter Challenge

11/22/2025

Spreading awareness about PDCD is crucial to helping us get DCA approved. You can help by participating in the 2025 Butter Challenge, beginning on November 22nd! More details coming soon.

IMG_1231.jpeg
Change.org Petition

10/30/2025

Join us in urging the FDA to approve DCA – the only treatment that has given PDCD kids stability and improved their lives – and to listen to PDCD families, meet our children, and hear our stories. This is not about lowering the bar for scientific evidence. It’s recognizing that for rare diseases, the bar must be different. 

Screen Shot 2025-11-16 at 2.11.47 AM.png
Saol Therapeutics Presentation

9/18/2025

Presentation on the DCA clinical trial, FDA decision, and what comes next. Huge thank you to both Saol Therapeutics and Hope for PDCD for putting on this extremely informative webinar.

SaolPresentation.png
Mito Advocacy groups respond to FDA's DCA denial

9/4/2025

United Mitochondrial Disease Foundation (UMDF), Mito Action, Cure Mito, Hope for PDCD, and the Elizabeth Watt Research Fund issue a joint statement and call to action.

umdf.png
Senate Hearing on Rare Disease Treatments

11/17/2025

The Senate Special Committee on Aging will be holding a hearing on rare disease treatment authorization. Mito advocacy groups sent a joint letter to the committee urging them to use the opportunity to elevate the voices of the PDCD community and the urgent need for DCA.

Untitled design.png
Physicians Letter to the FDA

10/8/2025

More than 80 of the leading researchers and clinicians in the mitochondrial disease space have signed a joint letter of support urging the FDA to pursue an expedited, flexible regulatory path forward for DCA

Screen Shot 2025-09-30 at 3.34.14 PM.png
Saol Therapeutics News Release

9/8/2025

News release regarding the FDA's response to their DCA application.

Saol news release.png

Benefits of DCA

Below are just some of the benefits kids with PDCD have seen while taking DCA:

Increased Energy

PDCD severely affects energy, any increase in energy has a huge quality of life impact for these kids

Less Restrictive Diet

Most kids with PDCD are on a very strict ketogenic diet, less restrictions mean they can eat a healthier diet with more fruit and vegetables

Decreased Pain

Decreased pain means more good days. When time with your loved one is limited, the good days are priceless

Better Sleep

Poor sleep is very common with PDCD, some kids have slept through the night for the first time on DCA

Increased Alertness

Kids are better able to process and enjoy the world around them, accelerating their learning

Lower Lactic Acid

Lactic acid can build up in the brain and central nervous system, putting kids at risk for seizure, stroke, coma, or worse​

Increased Life Expectancy

Typical life expectancy is early childhood, any extension of that is monumental to kids and their families

More Milestones Reached

Some kids have started walking, talking, and eating by mouth on DCA

“[My daughter] Harlow entered the [DCA] trial…and we saw changes no one could deny. She had more energy. Her mind was sharper. Her quality of life improved. DCA gave her what the ketogenic diet alone could not: stability, relief, and a glimpse of possibility.” 

Watch Now

Videos from the PDCD community
Talia’s first steps, months after starting DCA
Harlow's journey on DCA
Abby can't wait, she needs access to DCA now
Meet Talia, she is not just a number
DCA helps Talia transition from a feeding tube
Talia finds joy in movement with DCA
Talia sleeps through the night thanks to DCA
DCA is helping our kids and we have the data to prove it
Speech improvements with DCA
bottom of page